Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oman Healthcare News.
Press releases published on September 9, 2025
Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis
MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces it has dosed the first patient in a Phase 3 clinical trial aimed at expanding the indications for …
Significant Breakthrough! eefit Far Infrared Technology Improves Two Major Symptoms of Alzheimer’s Disease, Bringing New Hope to Brain Health Protection
Hong Kong, Sept. 09, 2025 (GLOBE NEWSWIRE) -- With Hong Kong’s aging population, Alzheimer’s disease has become a major public health challenge. The Hong Kong Council of Social Service projects that by 2036, the number of people with dementia in Hong Kong …
University Hospital Foundation announces project to support Alberta dementia patients and their families
Edmonton, AB, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The University Hospital Foundation is proud to launch the Dementia Care Pathways Project, a bold initiative aimed at transforming how we diagnose and support Albertans living with dementia in our communities …
Actuate Therapeutics Announces Proposed Public Offering of Common Stock
CHICAGO and FORT WORTH, Texas, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult …
Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance
MOUNTAIN VIEW, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar’s Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing WALTHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- OptimizeRx (the “Company”) …
InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2025
DENVER, Sept. 09, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All- …
Picard Medical, Inc. Announces Exercise of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering
TUCSON, Ariz., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that the underwriters of its previously announced initial public offering of common stock, par value $0.0001 per share …
Celcuity Announces Upsized Senior Secured Term Loan Facility of $500 Million with Innovatus Capital Partners and Oxford Finance
MINNEAPOLIS, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (“Celcuity”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it has entered into an amendment to its existing senior secured …
CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025
ZUG, Switzerland and BOSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that a late-breaking oral …
Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease
Transaction structured to provide flexible funding to support Phase 1b registrational clinical study program in advanced Parkinson’s under the 505(b)(2) NDA pathway Evaluating complementary funding including strategic equity and non-dilutive alternatives …
Tevogen Estimates 5-Year Top-Line Revenue of ∼$6.5 Billion For Product Focused on Liver Cancer Prevention with High-Risk Chronic Hepatitis B Infection
Risk adjusted Net Present Value (rNPV) for TVGN 116 is estimated to exceed ~$325 million in the US alone. WARREN, N.J., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today shared asset value and …
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance - Publication of Circular for Combined Annual General Meeting of September 30, 2025
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance Publication of Circular for Combined Annual General Meeting of September 30, 2025 Nantes, September 9, 2025, 8:30 p.m. CET - OSE Immunotherapeutics SA (ISIN: …
Le Conseil d’Administration appelle à soutenir une stratégie créatrice de valeur et une gouvernance ouverte - Publication des documents de convocation à l’Assemblée Générale Mixte du 30 septembre 2025
Le Conseil d’Administration appelle à soutenir une stratégie créatrice de valeur et une gouvernance ouverte Publication des documents de convocation à l’Assemblée Générale Mixte du 30 septembre 2025 NANTES, France – 9 septembre 2025, 20 heures 30 – OSE …
Booking Health Expands Access to Dendritic Cell Therapy After Study Confirms Survival Benefit in Glioblastoma Patients
Langenfeld, Germany, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Booking Health, a global medical travel platform, announced today the expansion of patient access to dendritic cell immunotherapy for recurrent glioblastoma, following the publication of new clinical …
Leading Health Organizations Call for Nutrition Education to Become a Core Part of Medical Training
Chicago, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Academy of Nutrition and Dietetics, together with 14 national health organizations, supports United States medical schools increasing the number of hours devoted to nutrition education in medical training. …
Leptomeningeal Metastases Market to Exhibit Growth at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight
New York, USA, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Leptomeningeal Metastases Market to Exhibit Growth at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight The leptomeningeal metastases market is projected to grow steadily due to …
Del Bigtree and ICAN Announce Senate Hearing on Science and Corruption, Featuring Groundbreaking Study and Announces Documentary, "An Inconvenient Study"
WASHINGTON, DC, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Informed Consent Action Network (ICAN), led by Emmy Award-winning producer and veteran medical journalist Del Bigtree, today calls attention to a crucial hearing of the U.S. Senate Permanent …
Acesis Biomed Appoints Dr. Frederic Fasano, Pharm.D, MBA, ICD.D to the Board of Directors as Chairman
CENTENNIAL, Colo., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Acesis Holdings Corporation (“Acesis Biomed”), a pre‑clinical stage biotechnology company pioneering oral treatments for metabolic and endocrine disorders linked to low testosterone in men, today …